Benjamin F. Edwards & Company, Inc. Sorrento Therapeutics, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$6.35 - $10.0 $63,500 - $100,000	-10,000 Reduced 50.0%	10,000 $97,000
Q1 2021 May 14, 2021	BUY	$7.03 - $16.51 $140,600 - $330,200	20,000 New	20,000 $165,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $2,468 - $7,528	-400 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $692 - $2,704	400 New	400 $3,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.